![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 16, 10912-10925, April 21, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
1


2
From the
Heinrich Pette Institute for Experimental Virology and Immunology, D-20251 Hamburg, Germany, the
Institute of Microbiology, Biochemistry, and Genetics, University Erlangen-Nürnberg, D-91054 Erlangen, Germany, the ¶Institute for Microbiology and Genetics, University of Göttingen, D-37077 Göttingen, Germany, the ||Department of Cell and Developmental Biology, Biocenter of the University of Würzburg, D-97074 Würzburg, Germany, and the **Center of Biochemistry and Molecular Cell Biology, University of Göttingen, D-37073 Göttingen, Germany
Dendritic cells are the most potent of the antigen-presenting cells and are characterized by surface expression of CD83. Here, we show that the coding region of CD83 mRNA contains a novel cis-acting structured RNA element that binds to HuR, a member of the ELAV family of AU-rich element RNA-binding proteins. Transient transfection of mammalian cells demonstrated that this CD83 mRNA-derived element acts as a post-transcriptional regulatory element in cells overexpressing HuR. Notably, binding of HuR to the CD83 post-transcriptional regulatory element did not affect mRNA stability. Using RNA interference, we show that HuR mediated efficient expression of CD83. In particular, HuR was required for cytoplasmic accumulation of CD83 transcripts. Likewise, inhibition of the CRM1 nuclear export pathway by leptomycin B or overexpression of a defective form of the nucleoporin Nup214/CAN diminished cytoplasmic CD83 mRNA levels. In summary, the data presented demonstrate that the HuR-CRM1 axis affects the nucleocytoplasmic translocation of CD83 mRNA under regular physiological conditions.
Received for publication, September 20, 2005 , and in revised form, January 23, 2006.
* This work was supported by Wilhelm Sander Stiftung Grant 2003.033.1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed: Heinrich Pette Inst. for Experimental Virology and Immunology, Martinistrasse 52, D-20251 Hamburg, Germany. Tel.: 49-40-4805-1241; Fax: 49-40-4805-1184; E-mail: joachim.hauber{at}hpi.uni-hamburg.de.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. W. Shineman, B. Zhang, S. N. Leight, D. Pratico, and V. M.-Y. Lee Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice J. Neurosci., April 30, 2008; 28(18): 4785 - 4794. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, I. Borecki, L. Nguyen, D. Ma, K. Smith, P. C. Huettner, D. G. Mutch, T. J. Herzog, R. K. Gibb, M. A. Powell, et al. CD83 Gene Polymorphisms Increase Susceptibility to Human Invasive Cervical Cancer Cancer Res., December 1, 2007; 67(23): 11202 - 11208. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. David, R. Tanveer, and J. D. Port FRET-detectable interactions between the ARE binding proteins, HuR and p37AUF1 RNA, September 1, 2007; 13(9): 1453 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kuwano, C. M. Prazma, N. Yazawa, R. Watanabe, N. Ishiura, A. Kumanogoh, H. Okochi, K. Tamaki, M. Fujimoto, and T. F. Tedder CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells Int. Immunol., August 1, 2007; 19(8): 977 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. A. Khabar Rapid transit in the immune cells: the role of mRNA turnover regulation J. Leukoc. Biol., June 1, 2007; 81(6): 1335 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fries, J. Heukeshoven, I. Hauber, C. Gruttner, C. Stocking, R. H. Kehlenbach, J. Hauber, and J. Chemnitz Analysis of Nucleocytoplasmic Trafficking of the HuR Ligand APRIL and Its Influence on CD83 Expression J. Biol. Chem., February 16, 2007; 282(7): 4504 - 4515. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |